Schedule 13G/A
MURA Schedule 13G/A filing by BlackRock
BlackRock reported beneficial ownership of 342.6K shares, representing 2% of MURAL ONCOLOGY PLC in this filing.
FiledJul 8, 2024
Ownership dateJun 30, 2024
Reported shares342.6K
Reported ownership2%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
342.6K
Shared voting power
342.6K
Sole dispositive power
342.6K
Shared dispositive power
342.6K
Compared with the prior filing
How the reported position changed
This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for MURA. A change between filings does not by itself establish when shares were bought or sold.
Previous filingFeb 2, 2024
Reported share change-830,378
Ownership percentage change-5 pts
| Previous filing | This filing | |
|---|---|---|
| Reported shares | 1.2M | 342.6K |
| Reported ownership | 7% | 2% |
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- BlackRock
- CIK
- CIK0001364742
- Accession
- 0001086364-24-008199
- Form
- Schedule 13G/A
Read the filing in context